BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Policy

  Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine

  Sanofi and GSK announce that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccine.

  February 23, 2022

   · 

  9 min read
• Business

  Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance

  Integra LifeSciences Holdings Corporation reported financial results for the fourth quarter and full year ended December 31, 2021, consistent with its preliminary revenue results announced on January 11, 2022.

  February 23, 2022

   · 

  27 min read
• Biotech Beach

  Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System

  Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced that they have commenced the commercial launch of their push-button needle, to be used as part of Kurin blood culture sets.

  February 23, 2022

   · 

  1 min read
• Business

  G1 Therapeutics Provides Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

  G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today provided a corporate and financial update for the fourth quarter and full year ended December 31, 2021.

  February 23, 2022

   · 

  15 min read
• Business

  Lupin Announces Executive Leadership Change

  Global pharma major, Lupin Limited (Lupin) announced today changes to its executive team with Dr. Fabrice Egros assuming responsibilities for Global Corporate Development as President, Corporate Development and Growth Markets.

  February 23, 2022

   · 

  2 min read
• Business

  Mirion Technologies Announces Results for the Fiscal Quarter and Fiscal Year Ended December 31, 2021

  Mirion Technologies, Inc. today announced results for its fiscal quarter and fiscal year ended December 31, 2021.

  February 23, 2022

   · 

  23 min read
• Business

  Amryt to Report FY and Q4 2021 Results on March 9, 2022

  Amryt today announces that its unaudited financial results for the fourth quarter 2021 and full year ended December 31, 2021 will be released on Wednesday, March 9, 2022 at 0700 EST / 1200 GMT.

  February 23, 2022

   · 

  5 min read
• BioMidwest

  Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego FacilityFull Scope of New Service Capabilities to be Operational in Q2; Company Has Already Secured Project Commitments from Multiple New Clients

  Recro Pharma, Inc. reported key progress in adding fill/finish and lyophilization capabilities to its broad suite of CDMO offerings.

  February 23, 2022

   · 

  5 min read
• Business

  BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones

  BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported financial results for the fourth quarter and full year ended December 31, 2021.

  February 23, 2022

   · 

  16 min read
• Business

  Algernon Pharmaceuticals Begins Manufacturing of Repirinast and Launches New Chronic Kidney Disease Research Program

  Algernon Pharmaceuticals Inc is pleased to announce that it has awarded a contract to Zhejiang Ausun Pharmaceutical CO, LTD of China to begin the manufacturing of a cGMP supply of its repurposed drug candidate NP-251 (“Repirinast”) and has initiated a new chronic kidney disease (“CKD”) research program.

  February 23, 2022

   · 

  8 min read